Search - tctmd.com

Displaying 121 - 140 of 148

Sort: Relevancy | Date

Presentation

Prevalence of Anginal Symptoms and Myocardial Ischemia and Their Effect on Clinical Outcomes in Outpatients With Stable CAD

Presenter: Philippe Gabriel Steg

August 15, 2014

Presentation BRS 2014

Bioresorbable Scaffolds and Angina post-PCI: A New Paradigm Shifting Hypothesis

Presenter: Dean J. Kereiakes

July 25, 2014

$Approaches to Refractory Angina: Cell Therapy vs Advanced PCI for CTO$

Presentation TCT 2013

Approaches to Refractory Angina: Cell Therapy vs Advanced PCI for CTO

Presenter: Timothy Henry

October 29, 2013

Presentation TCT 2013

PCI vs. Medical Therapy to Improve Exercise Capacity and Relieve Angina in SIHD: Prior Studies and Rationale for a New Randomized Trial

Presenter: Justin Davies

October 29, 2013

Presentation TCT 2013

Stable Angina: PCI vs. CABG vs. OMT

Presenter: Thomas Tu

October 27, 2013

Presentation

Prasugrel vs. Clopidogrel for Patients with Unstable Angina or NSTEMI With or Without Angiography

Presenter: Stephen D. Wiviott

August 20, 2013

$The Coronary Sinus Reducer – a Device Based Therapy for Refractory Angina; Interim Safety Results of the ongoing COSIRA clinical Trial and efficacy results of the CS Reducer...$

Presentation TCT 2013

The Coronary Sinus Reducer – a Device Based Therapy for Refractory Angina; Interim Safety Results of the ongoing COSIRA clinical Trial and efficacy results of the CS Reducer...

Presenter: Shmuel Banai, Marc Jolicoeur, Jean-Fran?ois Tanguay, Elazer Edelman, Stefan Verheye

January 31, 2013

Presentation

Preinfarction Angina Reduces Infarct Size in STEMI Patients Treated with PCI

Presenter: R. Reiter

January 31, 2013

Presentation TCT 2013

One year clinical outcome of biodegradable and permanent polymer drug-eluting stents for multivessel disease or long lesion (?28mm) in patients with stable and unstable angina

Presenter: Jun-Won Lee, Sung Gyun Ahn, Ji-Hyun Lee, Seung-Hwan Lee, Junghan Yoon, Young-Jin Youn

January 31, 2013

Presentation TCT 2013

Nicorandil Prevents Microvascular Dysfunction Resulting from Percutaneous Coronary Intervention in Patients with Stable Angina Pectoris

Presenter: Atsushi Hirohata, Eiki Hirose, Yuhei Kobayashi, Minako Ohara, Tohru Ohe, Fumihiko Sano, Hiroya Takafuji, Hiroyuki Takinami, Keizo Yamamoto, Ryo Yoshioka

January 31, 2013

Presentation TCT 2013

Impact of Ad Hoc Percutaneous Coronary Intervention with Drug-Eluting Stent in Angina Patients

Presenter: Young-Hak Kim, Duk-Woo Park, Jung-Min Ahn, Gyung-Min Park, Hae Geun Song, Jong-Young Lee, Won-Jang Kim, Sung-Cheol Yun, Soo-Jin Kang, Seung-Whan Lee, Cheol Whan Lee, Seong-Wook Park, Seung-Jung Park

January 31, 2013

Presentation TCT 2013

Comparison of Coronary Plaque Components between Non-Culprit Lesion in Patients with Acute Coronary Syndrome and Target Lesion in Patients with Stable Angina: Virtual...

Presenter: Young Joon Hong, Myung Ho Jeong, Yun Ha Choi, Soo Young Park, Jae Yeong Cho, Hae Chang Jeong, Sang Cheol Cho, Su Young Jang, Ji Eun Song, Jong Hyun Yoo, Doo Sun Sim, Keun Ho Park, Ju Han Kim, Youngkeun Ahn, Jeong Gwan Cho, Jong Chun Park, Jung Chaee Kang

January 31, 2013

Presentation TCT 2013

Association of Myocardial Bridge and Acetylcholine Dose Response in Patients with Vasospastic Angina

Presenter: Sung Il Im, Seung-Woon Rha, Byoung Geol Choi, Se Yeon Choi, Sun Won Kim, Jin Oh Na, Seong Woo Han, Cheol Ung Choi, Hong Euy Lim, Jin Won Kim, Eung Ju Kim, Chang Gyu Park, Hong Seog Seo, Dong Joo Oh

January 31, 2013

Presentation TCT 2013

A United Kingdom Perspective on the Appropriateness of Percutaneous Coronary Intervention in Stable Angina

Presenter: Benjamin Wrigley, Nikesh Malik, Amerjeet Banning, Raj Rajendra, Gail Richardson, Anthony Gershlick

January 31, 2013

Presentation TCT 2013

Impact of Anti-anginal Therapy and Rate Pressure Product Control on the Need for Repeat Revascularization Post-PCI

Presenter: Subhash Banerjee, Rick Weideman, Bertis Little, Mark Weideman, Jennifer Gunter, Kevin Kelly, Emmanouil Brilakis

January 31, 2013

$Intramyocardial injection of MSCs in patients with severe stable coronary artery disease and refractory angina - final 3 year follow-up$

Presentation Cell Therapy 2013

Intramyocardial injection of MSCs in patients with severe stable coronary artery disease and refractory angina - final 3 year follow-up

Presenter: Anders Bruun Mathiasen

January 23, 2013

$Mobilized CD34+ Cells for Refractory Angina: Design and Update for the Phase 3 RENEW Study$

Presentation Cell Therapy 2013

Mobilized CD34+ Cells for Refractory Angina: Design and Update for the Phase 3 RENEW Study

Presenter: Thomas J. Povsic

January 22, 2013

Presentation TCT 2012

Case 2: Patient with Stable Class 3 Angina, Triple-Vessel CAD, and Intermediate Syntax and STS Scores(2)

Presenter: Megan Coylewright

October 26, 2012

Presentation TCT 2012

Case 1: Patient with Stable Class 1 Angina Treated with Aspirin and Statin and a Mid LAD 70% Stenosis

Presenter: Megan Coylewright

October 26, 2012

Presentation TCT 2012

Case 1: Patient with Stable Class 1 Angina Treated with Aspirin and Statin and a Mid LAD 70% Stenosis(2)

Presenter: Megan Coylewright

October 26, 2012

Advertisement

Prevalence of Anginal Symptoms and Myocardial Ischemia and Their Effect on Clinical Outcomes in Outpatients With Stable CAD

Bioresorbable Scaffolds and Angina post-PCI: A New Paradigm Shifting Hypothesis

Approaches to Refractory Angina: Cell Therapy vs Advanced PCI for CTO

PCI vs. Medical Therapy to Improve Exercise Capacity and Relieve Angina in SIHD: Prior Studies and Rationale for a New Randomized Trial

Stable Angina: PCI vs. CABG vs. OMT

Prasugrel vs. Clopidogrel for Patients with Unstable Angina or NSTEMI With or Without Angiography

The Coronary Sinus Reducer – a Device Based Therapy for Refractory Angina; Interim Safety Results of the ongoing COSIRA clinical Trial and efficacy results of the CS Reducer...

Preinfarction Angina Reduces Infarct Size in STEMI Patients Treated with PCI

One year clinical outcome of biodegradable and permanent polymer drug-eluting stents for multivessel disease or long lesion (?28mm) in patients with stable and unstable angina

Nicorandil Prevents Microvascular Dysfunction Resulting from Percutaneous Coronary Intervention in Patients with Stable Angina Pectoris

Impact of Ad Hoc Percutaneous Coronary Intervention with Drug-Eluting Stent in Angina Patients

Comparison of Coronary Plaque Components between Non-Culprit Lesion in Patients with Acute Coronary Syndrome and Target Lesion in Patients with Stable Angina: Virtual...

Association of Myocardial Bridge and Acetylcholine Dose Response in Patients with Vasospastic Angina

A United Kingdom Perspective on the Appropriateness of Percutaneous Coronary Intervention in Stable Angina

Impact of Anti-anginal Therapy and Rate Pressure Product Control on the Need for Repeat Revascularization Post-PCI

Intramyocardial injection of MSCs in patients with severe stable coronary artery disease and refractory angina - final 3 year follow-up

Mobilized CD34+ Cells for Refractory Angina: Design and Update for the Phase 3 RENEW Study

Case 2: Patient with Stable Class 3 Angina, Triple-Vessel CAD, and Intermediate Syntax and STS Scores(2)

Case 1: Patient with Stable Class 1 Angina Treated with Aspirin and Statin and a Mid LAD 70% Stenosis

Case 1: Patient with Stable Class 1 Angina Treated with Aspirin and Statin and a Mid LAD 70% Stenosis(2)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content